ANI Pharmaceuticals | ANIP - Equity Capital And Reserves


ANI Pharmaceuticals reported $505.82M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
ANI Pharmaceuticals USD 505.82M 69.06M Sep/2025
Assertio Holdings USD 105.8M 12.5M Sep/2025
Aurora Cannabis CAD 567.1M 21.58M Sep/2025
Canopy Growth CAD 736.01M 247.04M Sep/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Emergent BioSolutions USD 649.3M 47.9M Dec/2023
Heron Therapeutics USD 14.88M 42.14M Sep/2025
Hikma Pharmaceutical USD 2.55B 230M Jun/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Novartis USD 44.33B 2.28B Sep/2025
Omeros USD -228.68M 15.13M Jun/2025
Perrigo USD 4.45B 25.8M Sep/2025
Sun Pharmaceuticals INR 778.2B 56.02B Sep/2025
Teva Pharmaceutical Industries USD 7.91B 664M Dec/2025